iWriteGigs

Fresh Grad Lands Job as Real Estate Agent With Help from Professional Writers

People go to websites to get the information they desperately need.  They could be looking for an answer to a nagging question.  They might be looking for help in completing an important task.  For recent graduates, they might be looking for ways on how to prepare a comprehensive resume that can capture the attention of the hiring manager

Manush is a recent graduate from a prestigious university in California who is looking for a job opportunity as a real estate agent.  While he already has samples provided by his friends, he still feels something lacking in his resume.  Specifically, the he believes that his professional objective statement lacks focus and clarity. 

Thus, he sought our assistance in improving editing and proofreading his resume. 

In revising his resume, iwritegigs highlighted his soft skills such as his communication skills, ability to negotiate, patience and tactfulness.  In the professional experience part, our team added some skills that are aligned with the position he is applying for.

When he was chosen for the real estate agent position, he sent us this thank you note:

“Kudos to the team for a job well done.  I am sincerely appreciative of the time and effort you gave on my resume.  You did not only help me land the job I had always been dreaming of but you also made me realize how important adding those specific keywords to my resume!  Cheers!

Manush’s story shows the importance of using powerful keywords to his resume in landing the job he wanted.

Mastery EAQ Ch. 26

Navigation   » List of Schools  »  International College of Health Sciences  »  Nursing  »  Nursing 1141- Pharmacology  »  Fall 2022  »  Mastery EAQ Ch. 26

Need help with your exam preparation?

Below are the questions for the exam with the choices of answers:

Question #1
A  The dose will be decreased.
B  The dose will be increased.
C  The medication will be stopped.
D  The dose will be unchanged.
Question #2
A  Is a candidate for fondaparinux based on a sufficient creatinine clearance and adequate body weight
B  Not a candidate for fondaparinux based on an insufficient creatinine clearance
C  Is a candidate for fondaparinux based on sufficient creatinine clearance and after body weight attains an adequate level
D  Not a candidate for fondaparinux based on both an insufficient creatinine clearance and an inadequate body weight
Question #4
A  Significantly elevated
B  Significantly decreased
C  Within normal limits
D  Inadequate to evaluate treatment
Question #5
A  Monitor liver enzymes.
B  Administer prescribed vitamin K if bruising is observed.
C  Assess for dysrhythmias.
D  Stop the medication if the systolic blood pressure drops below 110 mm Hg.
Question #6
A  Administering the medication when convenient
B  Massaging the site after the injection
C  Checking if the patient’s prescription contains enoxaparin
D  Administering the medication intramuscularly in the vastus lateralis
Question #7
A  “I refrain from drinking coffee and citrus fruit juices daily.”
B  “I do not take aspirin for pain relief.”
C  “I take ginkgo supplements for memory enhancement.”
D  “I eat 1 cup of green leafy vegetables daily.”
Question #8
A  “I avoid tight-fitting stockings or leggings.”
B  “I’ve been on prolonged bed rest.”
C  “I never sit with my legs crossed at the knees.”
D  “I get up and walk around at least once an hour.”
Question #11
A  Heart rate, Hemoglobin, Blood pressure
B  Platelet count, Heart rate, Blood pressure
C  Hemoglobin, Platelet count, Activated partial thromboplastin time (aPTT)
D  Activated partial thromboplastin time (aPTT), Blood pressure, Heart rate
Question #12
A  “I will take the medication with food.”
B  “I will store the bottle in a dry place.”
C  “I will use the medication within 60 days after it is opened.”
D  “I will place the pills in an organizer for easy use.”
Question #13
A  Loss of 10 pounds
B  Creatinine clearance of 25 mL/min
C  Diagnosis of diabetes mellitus
D  Platelet count of 80,000/mm3
Question #14
A  The dosage of the amiodarone will be decreased by half.
B  The dosage of the warfarin will be increased by half.
C  The dosage of the warfarin will be decreased by half.
D  The dosage of the amiodarone will be increased by half.
Question #15
A  Monitor the patient for increased action of the anticoagulant.
B  Continue to administer cimetidine with each dose of warfarin.
C  Instruct the patient to notify the nurse if he or she begins to experience discomfort.
D  Monitor the patient for decreased action of the anticoagulant.
Question #16
A  Local thrombosis from a peripheral intravenous line
B  Peptic ulcer disease
C  Severe chest pain for the past 2 hours
D  Gastrointestinal bleed
Question #17
A  Notify the health care provider immediately.
B  Increase the dose of heparin.
C  Monitor the patient and check the therapeutic range.
D  Stop the medication.
Question #18
A  Outside the expected target therapeutic level of anticoagulation; it is too low
B  Outside the expected target therapeutic level of anticoagulation; it is too high
C  Cannot be interpreted without knowing the prothrombin time and international normalized ratio
D  Within the expected target therapeutic level of anticoagulation
Question #19
A  Prothrombin time: 13 sec
B  Leukocyte count: 3000 cells/mm3
C  Platelet count: 100,000/mm3
D  Hemoglobin level: 11 g/dL
Question #20
A  Peptic ulcer disease, Chronic kidney disease
B  History of myocardial infarction, Chronic obstructive pulmonary disease
C  Chronic obstructive pulmonary disease, Atrial fibrillation
D  Atrial fibrillation, History of myocardial infarction
Question #21
A  Platelet count of 95,000/mm3
B  Activated partial thromboplastin time (aPTT) of 37 seconds
C  Potassium level of 3.5 mEq/L
D  International normalized ratio (INR) of 1
Question #22
A  Outside the expected target therapeutic level of anticoagulation; it is too high
B  Within the expected target therapeutic level of anticoagulation
C  The prothrombin time and activated partial thromboplastin time (aPTT) value are needed to interpret the finding.
D  Outside the expected target therapeutic level of anticoagulation; it is too low
Question #23
A  “Refrigerate and keep away from direct sunlight.”
B  “Discard the drug within 21 days of opening the original container.”
C  “Remove from the original package and place in aluminum foil.”
D  “Store the drug with the desiccant-drying agent in the packing cap.”
Question #25
A  Teach the patient about dietary restrictions while on the medication.
B  Ensure that a loading dose was initially administered when beginning
C  Monitor the patient’s laboratory values correctly.
D  Have protamine sulfate readily available at all times.
Question #26
A  Administer vitamin K1 (phytonadione) IV.
B  Stop the intravenous (IV) drip.
C  Wait for the INR to decrease.
D  Administer protamine sulfate IV.
Question #27
A  A quick decrease in pain
B  Reversal of damage from the infarction
C  Dissolution of the clot that caused the heart attack
D  Prevention of new clots from forming
Question #28
A  “I should not use any acetaminophen during the therapy.”
B  “I should follow a low-cholesterol diet during the therapy.”
C  “I should take oral contraceptives during the therapy.”
D  “I should refrain from eating broccoli during the therapy.”
Question #29
A  “I should keep taking ibuprofen for my arthritis.”
B  “I will double my dose if I forget to take it the day before.”
C  “I should use a soft toothbrush for dental hygiene.”
D  “I should decrease the dose if I start bruising easily.”
Question #30
A  “The only difference is that regular heparin dosing is based on the patient’s weight.”
B  “You should ask your doctor why dalteparin was ordered instead of regular heparin.”
C  “Dalteparin is a low-molecular-weight heparin that is more predictable in its effect and has a lower risk of bleeding.”
D  “There is no real difference; dalteparin is interchangeable with regular heparin.”
Question #31
A  Draw up the medication in a syringe with a 22-gauge, 1.5-inch needle.
B  Administer the medication into subcutaneous tissue of the abdomen.
C  Utilize the Z-track method to inject the medication.
D  Rub the administration site after injecting.
Question #32
A  “I will increase dark green leafy vegetables in my diet.”
B  “I will avoid contact sports.”
C  “I will take my medication at the same time each day.”
D  “I will contact my health care provider if I develop excessive bruising.”
Question #34
A  Recombinant factors
B  Warfarin daily
C  Vitamin K daily
D  Aspirin daily (i.e., 81 mg)
Question #35
A  Peripheral vascular disease
B  Transient ischemic attack
C  Vitamin K deficiency
D  Acute unstable angina
Question #36
A  Dabigatran orally
B  Heparin subcutaneously
C  Warfarin orally
D  Enoxaparin intramuscularly
Question #37
A  Ingestion of acetaminophen
B  Urine culture
C  Platelet level
D  Over-the-counter medications
Question #40
A  Blood urea nitrogen (BUN) level of 12 mg/dL
B  International normalized ratio (INR) of 1.0
C  Activated partial thromboplastin time (aPTT) of 120 seconds
D  Platelet count of 150,000 mm3
Question #41
A  Fasting blood glucose level of 95 mg/dL
B  Creatinine clearance value of 40 mL/min
C  Platelet count of 75,000 cell/μL
D  Hemoglobin level of 16.5 g/dL
Question #42
A  Vitamin K
B  Factor Xa
C  Antithrombin III
D  Thrombin
Question #43
A  Desmopressin
B  Tranexamic acid
C  Aminocaproic acid
D  Alteplase
Question #44
A  Antifibrinolytic
B  Thrombolytic
C  Antiplatelet
D  Anticoagulant
Question #45
A  Cardiomyopathy
B  Heart failure
C  Coronary artery disease
D  Acute myocardial infarction
Question #47
A  Enoxaparin
B  Dabigatran
C  Fondaparinux
D  Argatroban
Question #48
A  Selective factor Xa inhibitors
B  Direct thrombin inhibitors
C  Warfarin
D  Heparins
Question #49
A  Anticoagulants interfere with drug metabolism.
B  Anticoagulants prevent clots from forming.
C  Anticoagulants alter platelet function.
D  Anticoagulants dissolve clots.
Question #50
A  Thrombolytic
B  Antiplatelet
C  Antifibrinolytic
D  Anticoagulant
Question #51
A  Fatigue from walking with pain
B  Embolus to the lungs
C  Medication reaction
D  Anxiety
Question #52
A  Infusing 50 mL of warfarin sodium
B  Administering vitamin K1
C  Increasing the dose of enoxaparin
D  Administering protamine sulfate